108
Views
4
CrossRef citations to date
0
Altmetric
Conference Proceedings

Toll-Like receptor 4 (TLR4) polymorphism rs2149356 and risk of gout in a Spanish cohort

ORCID Icon
Pages 1424-1431 | Received 11 Sep 2019, Accepted 04 Jun 2020, Published online: 18 Jun 2020

References

  • Dalbeth, N.; Merriman, T. R.; Stamp, L. K. Gout. Lancet 2016, 388, 2039–2052. DOI: 10.1016/S0140-6736(16)00346-9.
  • Martinon, F.; Pétrilli, V.; Mayor, A.; Tardivel, A.; Tschopp, J. Gout-Associated Uric Acid Crystals Activate the NALP3 Inflammasome. Nature 2006, 440, 237–241. DOI: 10.1038/nature04516.
  • Choi, A. J.; Ryter, S. W. Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases. Mol. Cells. 2014, 37, 441–448. DOI: 10.14348/molcells.2014.0104.
  • Jo, E. K.; Kim, J. K.; Shin, D. M.; Sasakawa, C. Molecular Mechanisms Regulating NLRP3 Inflammasome Activation. Cell. Mol. Immunol. 2016, 13, 148–159. DOI: 10.1038/cmi.2015.95.
  • Dalbeth, N.; Phipps-Green, A.; Frampton, C.; Neogi, T.; Taylor, W. J.; Merriman, T. R. Relationship between Serum Urate Concentration and Clinically Evident Incident Gout: An Individual Participant Data Analysis. Ann. Rheum. Dis. 2018, 77, 1048–1052. DOI: 10.1136/annrheumdis-2017-212288.
  • Stark, K.; Reinhard, W.; Neureuther, K.; Wiedmann, S.; Sedlacek, K.; Baessler, A.; Fischer, M.; Weber, S.; Kaess, B.; Erdmann, J.; et al. Association of Common Polymorphisms in GLUT9 Gene with Gout but Not with Coronary Artery Disease in a Large Case-Control Study. PLoS One. 2008, 3, e1948. DOI: 10.1371/journal.pone.0001948.
  • Dehghan, A.; Köttgen, A.; Yang, Q.; Hwang, S. J.; Kao, W. L.; Rivadeneira, F.; Boerwinkle, E.; Levy, D.; Hofman, A.; Astor, B. C.; et al. Association of Three Genetic Loci with Uric Acid Concentration and Risk of Gout: A Genome-Wide Association Study. Lancet 2008, 372, 1953–1961. DOI: 10.1016/S0140-6736(08)61343-4.
  • Kolz, M.; Johnson, T.; Sanna, S.; Teumer, A.; Vitart, V.; Perola, M.; Mangino, M.; Albrecht, E.; Wallace, C.; Farrall, M.; et al. Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations. PLoS Genet. 2009, 5, e1000504. DOI: 10.1371/journal.pgen.1000504.
  • Hollis-Moffatt, J. E.; Xu, X.; Dalbeth, N.; Merriman, M. E.; Topless, R.; Waddell, C.; Gow, P. J.; Harrison, A. A.; Highton, J.; Jones, P. B.; et al. Role of the Urate Transporter SLC2A9 Gene in Susceptibility to Gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum. 2009, 60, 3485–3492. DOI: 10.1002/art.24938.
  • Yang, Q.; Köttgen, A.; Dehghan, A.; Smith, A. V.; Glazer, N. L.; Chen, M. H.; Chasman, D. I.; Aspelund, T.; Eiriksdottir, G.; Harris, T. B.; et al. Multiple Genetic Loci Influence Serum Urate Levels and Their Relationship with Gout and Cardiovascular Disease Risk Factors. Circ. Cardiovasc. Genet. 2010, 3, 523–530. DOI: 10.1161/CIRCGENETICS.109.934455.
  • Tu, H. P.; Chen, C. J.; Tovosia, S.; Ko, A. M.; Lee, C. H.; Ou, T. T.; Lin, G. T.; Chang, S. J.; Chiang, S. L.; Chiang, H. C.; et al. Associations of a non-synonymous Variant in SLC2A9 with Gouty Arthritis and Uric Acid Levels in Han Chinese Subjects and Solomon Islanders. Ann. Rheum. Dis. 2010, 69, 887–890. DOI: 10.1136/ard.2009.113357.
  • Köttgen, A.; Albrecht, E.; Teumer, A.; Vitart, V.; Krumsiek, J.; Hundertmark, C.; Pistis, G.; Ruggiero, D.; O'Seaghdha, C. M.; Haller, T.; et al. Genome-Wide Association Analyses Identify 18 New Loci Associated with Serum Urate Concentrations. Nat. Genet. 2013, 45, 145–154. DOI: 10.1038/ng.2500.
  • Liu-Bryan, R.; Scott, P.; Sydlaske, A.; Rose, D. M.; Terkeltaub, R. Innate Immunity Conferred by Toll-like Receptors 2 and 4 and Myeloid Differentiation Factor 88 Expression is Pivotal to Monosodium Urate Monohydrate Crystal-Induced Inflammation. Arthritis Rheum. 2005, 52, 2936–2946. DOI: 10.1002/art.21238.
  • Xiao, J.; Zhang, X. L.; Fu, C.; Han, R.; Chen, W.; Lu, Y.; Ye, Z. Soluble Uric Acid Increases NALP3 Inflammasome and Interleukin-1β Expression in Human Primary Renal Proximal Tubule Epithelial Cells through the Toll-like Receptor 4-Mediated Pathway. Int. J. Mol. Med. 2015, 35, 1347–1354. DOI: 10.3892/ijmm.2015.2148.
  • Qing, Y. F.; Zhou, J. G.; Zhang, Q. B.; Wang, D. S.; Li, M.; Yang, Q. B.; Huang, C. P.; Yin, L.; Pan, S. Y.; Xie, W. G.; et al. Association of TLR4 Gene rs2149356 Polymorphism with Primary Gouty Arthritis in a Case-Control Study. PLoS One. 2013, 8, e64845. DOI: 10.1371/journal.pone.0064845.
  • Rasheed, H.; McKinney, C.; Stamp, L. K.; Dalbeth, N.; Topless, R. K.; Day, R.; Kannangara, D.; Williams, K.; Smith, M.; Janssen, M.; et al. The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets. PLoS One. 2016, 11, e0147939DOI: 10.1371/journal.pone.0147939.
  • Torres, R. J.; de Miguel, E.; Bailén, R.; Banegas, J. R.; Puig, J. G. Tubular Urate Transporter Gene Polymorphisms Differentiate Patients with Gout Who Have Normal and Decreased Urinary Uric Acid Excretion. J. Rheumatol. 2014, 41, 1863–1870. DOI: 10.3899/jrheum.140126.
  • Wallace, S. L.; Robinson, H.; Masi, A. T.; Decker, J. L.; McCarty, D. J.; Yü, T.-F. Preliminary Criteria for the Classification of the Acute Arthritis of Primary gout. Arthritis Rheum. 1977, 20, 895–900. DOI: 10.1002/art.1780200320.
  • Mancia, G.; De Backer, G.; Dominiczak, A.; Cifkova, R.; Fagard, R.; Germano, G.; Grassi, G.; Heagerty, A. M.; Kjeldsen, S. E.; Laurent, S.; et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J. Hypertens. 2007, 25, 1751–1762. DOI: 10.1097/HJH.0b013e3282f0580f.
  • Lioté, F.; Pascart, T. From Hyperuricaemia to Gout: What Are the Missing Links? Nat. Rev. Rheumatol. 2018, 14, 448–449. DOI: 10.1038/s41584-018-0040-6.
  • So, A.K.; Martinon, F. Inflammation in Gout: Mechanisms and Therapeutic Targets. Nat. Rev. Rheumatol. 2017, 13, 639–647. DOI: 10.1038/nrrheum.2017.155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.